CA3235264A1 - Trem compositions and methods of use - Google Patents

Trem compositions and methods of use Download PDF

Info

Publication number
CA3235264A1
CA3235264A1 CA3235264A CA3235264A CA3235264A1 CA 3235264 A1 CA3235264 A1 CA 3235264A1 CA 3235264 A CA3235264 A CA 3235264A CA 3235264 A CA3235264 A CA 3235264A CA 3235264 A1 CA3235264 A1 CA 3235264A1
Authority
CA
Canada
Prior art keywords
trem
modification
naturally occurring
seq
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3235264A
Other languages
English (en)
French (fr)
Inventor
Theonie ANASTASSIADIS
David Charles Donnell Butler
Neil KUBICA
Qingyi Li
Nikolai Naryshkin
Armand Gatien NGOUNOU WETIE
Stephen William Eichhorn
William F. Kiesman
Christopher E. Arcadia
Hongchuan YU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flagship Pioneering Innovations VI Inc
Original Assignee
Flagship Pioneering Innovations VI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flagship Pioneering Innovations VI Inc filed Critical Flagship Pioneering Innovations VI Inc
Publication of CA3235264A1 publication Critical patent/CA3235264A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/50—Physical structure
    • C12N2310/53—Physical structure partially self-complementary or closed
    • C12N2310/531—Stem-loop; Hairpin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA3235264A 2021-10-13 2022-10-13 Trem compositions and methods of use Pending CA3235264A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202163255426P 2021-10-13 2021-10-13
US202163255420P 2021-10-13 2021-10-13
US63/255,426 2021-10-13
US63/255,420 2021-10-13
US202163284946P 2021-12-01 2021-12-01
US202163284934P 2021-12-01 2021-12-01
US63/284,934 2021-12-01
US63/284,946 2021-12-01
PCT/US2022/046632 WO2023064513A2 (en) 2021-10-13 2022-10-13 Trem compositions and methods of use

Publications (1)

Publication Number Publication Date
CA3235264A1 true CA3235264A1 (en) 2023-04-20

Family

ID=85987785

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3235264A Pending CA3235264A1 (en) 2021-10-13 2022-10-13 Trem compositions and methods of use

Country Status (11)

Country Link
US (1) US20240401047A1 (cg-RX-API-DMAC7.html)
EP (1) EP4416288A2 (cg-RX-API-DMAC7.html)
JP (1) JP2024538097A (cg-RX-API-DMAC7.html)
KR (1) KR20240107319A (cg-RX-API-DMAC7.html)
CN (1) CN120418430A (cg-RX-API-DMAC7.html)
AU (1) AU2022362286A1 (cg-RX-API-DMAC7.html)
CA (1) CA3235264A1 (cg-RX-API-DMAC7.html)
IL (1) IL311867A (cg-RX-API-DMAC7.html)
MX (1) MX2024004568A (cg-RX-API-DMAC7.html)
TW (1) TW202325313A (cg-RX-API-DMAC7.html)
WO (1) WO2023064513A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025080866A1 (en) * 2023-10-10 2025-04-17 Hc Bioscience, Inc. Trna therapeutics for hemophilia
CN117805381B (zh) * 2024-02-29 2024-05-28 首都医科大学附属北京积水潭医院 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用
WO2026073261A1 (en) * 2024-09-30 2026-04-02 Flagship Pioneering Innovations Vi, Llc Lipid nanoparticle formulations of trems
WO2026080471A2 (en) * 2024-10-07 2026-04-16 Flagship Pioneering Innovations Vi, Llc Compositions of trem conjugates and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5679147B2 (ja) * 2008-02-07 2015-03-04 独立行政法人理化学研究所 非天然塩基を含む改変tRNA及びその用途
WO2020069194A1 (en) * 2018-09-26 2020-04-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
JP2022534988A (ja) * 2019-05-31 2022-08-04 フラッグシップ パイオニアリング, インコーポレイテッド tRNAプールを調節するためのTREMの使用
JP7712270B2 (ja) * 2019-11-01 2025-07-23 テバード バイオサイエンシズ インコーポレイテッド 未成熟終止コドン媒介障害を処置するための方法および組成物
WO2021142343A1 (en) * 2020-01-09 2021-07-15 The Regents Of The University Of California Targeting transfer rna for the suppression of nonsense mutations in messenger rna
BR112022020780A2 (pt) * 2020-04-14 2022-11-29 Flagship Pioneering Innovations Vi Llc Composições de trem e usos das mesmas
US20230203510A1 (en) * 2020-05-29 2023-06-29 Flagship Pioneering Innovations Vi, Llc Trem compositions and methods relating thereto
KR20230135585A (ko) * 2020-12-23 2023-09-25 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 변형된 trem의 조성물 및 이의 용도

Also Published As

Publication number Publication date
US20240401047A1 (en) 2024-12-05
AU2022362286A1 (en) 2024-05-02
TW202325313A (zh) 2023-07-01
MX2024004568A (es) 2024-06-28
WO2023064513A9 (en) 2024-08-02
JP2024538097A (ja) 2024-10-18
WO2023064513A3 (en) 2023-06-15
KR20240107319A (ko) 2024-07-09
CN120418430A (zh) 2025-08-01
WO2023064513A2 (en) 2023-04-20
EP4416288A2 (en) 2024-08-21
IL311867A (en) 2024-06-01

Similar Documents

Publication Publication Date Title
US20230203510A1 (en) Trem compositions and methods relating thereto
US20240401047A1 (en) Trem compositions and methods of use
US20250340907A1 (en) Methods and compositions for modulating a genome
AU2017268397B2 (en) Polynucleotides encoding interleukin-12 (IL12) and uses thereof
ES2539188T3 (es) Complejos de ARN y péptidos catiónicos para transfección e inmunoestimulación
CN110719954B (zh) 用于iii型糖原贮积病的治疗剂
US20180258123A1 (en) Suppressors of Premature Termination Codons as Therapeutics and Methods for Their Use
BR112019015797A2 (pt) Composições de mrna terapêuticas imunomoduladoras que codificam peptídeos de mutação de oncogene de ativação
WO2015048577A2 (en) Crispr-related methods and compositions
JP6158833B2 (ja) ベータ−カテニン関連疾患を処置するための有機組成物
CA3214277A1 (en) Ltr transposon compositions and methods
WO2019143831A1 (en) Compositions and methods for increasing expression of scn2a
JP2024511437A (ja) ポリヌクレオチド組成物、関連製剤、およびその使用方法
CA3241414A1 (en) Nanoparticles and methods of production for the encapsulation of nucleic acids
EP4514956A2 (en) Compositions and methods for modulating a genome in t cells, induced pluripotent stem cells, and respiratory epithelial cells
US20230203509A1 (en) Trem compositions and methods relating thereto
TW202507003A (zh) Trem組合物及使用方法
US20250179492A1 (en) Compositions of modified trems and uses thereof
US20250313863A1 (en) ENGINEERED CIRCULARIZED pegRNAs AND USES THEREOF
WO2024035952A1 (en) Methods and compositions for modulating splicing at alternative splice sites
AU2024255972A1 (en) Modified trems, compositions, and related methods thereof
EA052416B1 (ru) КОМПОЗИЦИИ мРНК ДЛЯ ВНЕПЕЧЕНОЧНОЙ ДОСТАВКИ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ

Legal Events

Date Code Title Description
P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20240717

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250313

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD

Year of fee payment: 3

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20251003

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20251003

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20260206

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20260206

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-P146 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: BSL VERIFIED - NO DEFECTS

Effective date: 20260209